1. Home
  2. EDBL vs THAR Comparison

EDBL vs THAR Comparison

Compare EDBL & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDBL
  • THAR
  • Stock Information
  • Founded
  • EDBL 2020
  • THAR 2017
  • Country
  • EDBL United States
  • THAR United States
  • Employees
  • EDBL N/A
  • THAR N/A
  • Industry
  • EDBL Farming/Seeds/Milling
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDBL Consumer Staples
  • THAR Health Care
  • Exchange
  • EDBL Nasdaq
  • THAR Nasdaq
  • Market Cap
  • EDBL 5.7M
  • THAR 5.5M
  • IPO Year
  • EDBL 2022
  • THAR 2022
  • Fundamental
  • Price
  • EDBL $1.79
  • THAR $2.99
  • Analyst Decision
  • EDBL
  • THAR Strong Buy
  • Analyst Count
  • EDBL 0
  • THAR 1
  • Target Price
  • EDBL N/A
  • THAR $17.00
  • AVG Volume (30 Days)
  • EDBL 303.2K
  • THAR 29.2M
  • Earning Date
  • EDBL 08-14-2025
  • THAR 11-06-2025
  • Dividend Yield
  • EDBL N/A
  • THAR N/A
  • EPS Growth
  • EDBL N/A
  • THAR N/A
  • EPS
  • EDBL N/A
  • THAR N/A
  • Revenue
  • EDBL $12,320,000.00
  • THAR N/A
  • Revenue This Year
  • EDBL $29.56
  • THAR N/A
  • Revenue Next Year
  • EDBL $20.00
  • THAR N/A
  • P/E Ratio
  • EDBL N/A
  • THAR N/A
  • Revenue Growth
  • EDBL N/A
  • THAR N/A
  • 52 Week Low
  • EDBL $1.68
  • THAR $0.95
  • 52 Week High
  • EDBL $26.50
  • THAR $9.08
  • Technical
  • Relative Strength Index (RSI)
  • EDBL 28.44
  • THAR 46.71
  • Support Level
  • EDBL $1.68
  • THAR $4.94
  • Resistance Level
  • EDBL $2.62
  • THAR $7.25
  • Average True Range (ATR)
  • EDBL 0.17
  • THAR 1.54
  • MACD
  • EDBL 0.01
  • THAR -0.21
  • Stochastic Oscillator
  • EDBL 11.71
  • THAR 23.87

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: